المؤلفون: Victoria Higgins, Claus Vogelmeier, Mark Small, Jørgen Vestbo

المصدر: Vestbo, J, Vogelmeier, C, Small, M & Higgins, V 2014, ' Understanding the GOLD 2011 Strategy as applied to a real-world COPD population ', Respiratory Medicine, vol. 108, no. 5, pp. 729-736 . https://doi.org/10.1016/j.rmed.2014.03.002

مصطلحات موضوعية: Glucocorticoids/therapeutic use, Pediatrics, Exacerbation, Cross-sectional study, Professional Practice/statistics & numerical data, Comorbidity, Severity of Illness Index, Comorbidities, Pulmonary Disease, Chronic Obstructive, Inhaled corticosteroids Bronchodilators COPD Exacerbations Comorbidities GOLD document OBSTRUCTIVE PULMONARY-DISEASE EXACERBATIONS CLASSIFICATION BIOMARKERS GUIDELINES TIOTROPIUM OUTCOMES COHORT, Forced Expiratory Volume, Adrenergic beta-2 Receptor Agonists/therapeutic use, COPD, education.field_of_study, medicine.diagnostic_test, Inhaled corticosteroids, Drug Utilization/statistics & numerical data, Professional Practice, Middle Aged, Bronchodilator Agents, Disease Progression, Bronchodilator Agents/therapeutic use, Pulmonary and Respiratory Medicine, Spirometry, medicine.medical_specialty, Spirometry/methods, Forced Expiratory Volume/physiology, Population, GOLD document, Exacerbations, Bronchodilators, Administration, Inhalation, Severity of illness, medicine, Humans, Intensive care medicine, education, Adrenergic beta-2 Receptor Agonists, Glucocorticoids, Aged, business.industry, medicine.disease, Drug Utilization, Cross-Sectional Studies, Health Care Surveys, Pulmonary Disease, Chronic Obstructive/diagnosis, Observational study, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e821b66b6f9ff62ebc2916cf69680e0e
https://doi.org/10.1016/j.rmed.2014.03.002